185 related articles for article (PubMed ID: 17491551)
1. Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention.
Brtko J
Cent Eur J Public Health; 2007 Mar; 15(1):3-6. PubMed ID: 17491551
[TBL] [Abstract][Full Text] [Related]
2. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.
Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):187-94. PubMed ID: 18345250
[TBL] [Abstract][Full Text] [Related]
3. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention.
Brtko J; Thalhamer J
Curr Pharm Des; 2003; 9(25):2067-77. PubMed ID: 14529416
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
5. The relationship between renal cell carcinoma and nuclear retinoid/rexinoid receptors.
Lenko V; Bialesova L; Macejova D; Bujdak P; Breza J; Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):316-24. PubMed ID: 24077234
[TBL] [Abstract][Full Text] [Related]
6. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
[TBL] [Abstract][Full Text] [Related]
8. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
Uray IP; Dmitrovsky E; Brown PH
Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
[TBL] [Abstract][Full Text] [Related]
9. Retinoids in cancer chemoprevention.
Okuno M; Kojima S; Matsushima-Nishiwaki R; Tsurumi H; Muto Y; Friedman SL; Moriwaki H
Curr Cancer Drug Targets; 2004 May; 4(3):285-98. PubMed ID: 15134535
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
11. Role of retinoids, rexinoids and thyroid hormone in the expression of cytochrome p450 enzymes.
Brtko J; Dvorak Z
Curr Drug Metab; 2011 Feb; 12(2):71-88. PubMed ID: 21401514
[TBL] [Abstract][Full Text] [Related]
12. Retinoids and their receptors in cancer development and chemoprevention.
Sun SY; Lotan R
Crit Rev Oncol Hematol; 2002 Jan; 41(1):41-55. PubMed ID: 11796231
[TBL] [Abstract][Full Text] [Related]
13. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors.
Fanjul AN; Delia D; Pierotti MA; Rideout D; Yu JQ; Pfahl M
J Biol Chem; 1996 Sep; 271(37):22441-6. PubMed ID: 8798408
[TBL] [Abstract][Full Text] [Related]
15. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
Kim HT; Kong G; Denardo D; Li Y; Uray I; Pal S; Mohsin S; Hilsenbeck SG; Bissonnette R; Lamph WW; Johnson K; Brown PH
Cancer Res; 2006 Dec; 66(24):12009-18. PubMed ID: 17178900
[TBL] [Abstract][Full Text] [Related]
16. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid.
Zetterström RH; Lindqvist E; Mata de Urquiza A; Tomac A; Eriksson U; Perlmann T; Olson L
Eur J Neurosci; 1999 Feb; 11(2):407-16. PubMed ID: 10051741
[TBL] [Abstract][Full Text] [Related]
17. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
Lømo J; Smeland EB; Ulven S; Natarajan V; Blomhoff R; Gandhi U; Dawson MI; Blomhoff HK
J Cell Physiol; 1998 Apr; 175(1):68-77. PubMed ID: 9491782
[TBL] [Abstract][Full Text] [Related]
18. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer.
Picard E; Seguin C; Monhoven N; Rochette-Egly C; Siat J; Borrelly J; Martinet Y; Martinet N; Vignaud JM
J Natl Cancer Inst; 1999 Jun; 91(12):1059-66. PubMed ID: 10379969
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract][Full Text] [Related]
20. How retinoids regulate breast cancer cell proliferation and apoptosis.
Simeone AM; Tari AM
Cell Mol Life Sci; 2004 Jun; 61(12):1475-84. PubMed ID: 15197471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]